BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Press Releases

  Skye Bioscience Added to Russell 2000® and Russell 3000® Indexes

  Skye Bioscience, Inc. today announced the Company has been included in the Russell 2000 ® Index and the broad-market Russell 3000 ® Index, effective at the U.S. market open on July 1, 2024.

  July 1, 2024

   · 

  5 min read
• Business

  Avanos Medical, Inc. Appoints Indrani Franchini to Board of Directors

  Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Avanos board of directors.

  July 1, 2024

   · 

  2 min read
• Press Releases

  Novocure to Report Second Quarter 2024 Financial Results

  Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial markets open.

  July 1, 2024

   · 

  3 min read
• Press Releases

  Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.

  Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).

  July 1, 2024

   · 

  5 min read
• Drug Development

  ASPIRE-FTD Phase 1/2 Clinical Trial Opens in the U.S. at The Ohio State University Wexner Medical Center

  AviadoBio today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients in the United States at The Ohio State University.

  July 1, 2024

   · 

  7 min read
• Press Releases

  Neurogene Announces Addition to Russell 3000® Index

  Neurogene Inc. today announced that Neurogene will be added to the Russell 3000 ® Index, effective at the open of U.S. equity markets today, Monday, July 1, 2024.

  July 1, 2024

   · 

  5 min read
• Business

  Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Officer

  Vera Therapeutics, Inc. today announced the appointment of David L. Johnson as Chief Operating Officer, effective immediately.

  July 1, 2024

   · 

  9 min read
• FDA

  Syncromune Granted FDA Fast-Track Designation for SYNC-T SV-102 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

  Syncromune ® Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for SYNC-T SV-102 therapy, its lead candidate for the treatment of patients with metastatic castrate-resistant prostate cancer (mCRPC).

  July 1, 2024

   · 

  6 min read
• BioMidwest

  DiaMedica Therapeutics Announces Closing of $11.8 Million Private Placement

  DiaMedica Therapeutics Inc. today announced the closing of its previously announced $11.8 million private placement to accredited investors.

  July 1, 2024

   · 

  9 min read
• Drug Development

  Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium

  Artelo Biosciences, Inc. today announced Professor Saoirse O’Sullivan, Vice President of Translational Sciences at Artelo, presented preclinical data related to ART26.12.

  July 1, 2024

   · 

  5 min read